The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155 · see citing works

Angiogenesis in cancer and other diseases

Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · see citing works

Pattern Recognition Receptors and Inflammation

Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895 · see citing works

Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · see citing works

Hypoxia — a key regulatory factor in tumour growth

Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · see citing works

Fibroblasts in cancer

Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · see citing works

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496 · see citing works

Cellular and molecular mechanisms of fibrosis

Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495 · see citing works

Untitled work

(1989) · PubMed · Cited by 3,343 · see citing works

Immunogenic cell death and DAMPs in cancer therapy

Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223 · see citing works

The Three Es of Cancer Immunoediting

Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,087 · see citing works

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · see citing works

Exploiting tumour hypoxia in cancer treatment

Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · see citing works

Influence of tumour micro-environment heterogeneity on therapeutic response

Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694 · see citing works

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681 · see citing works

Molecular regulation of vessel maturation

Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,515 · see citing works

Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection

Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103 · see citing works

Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice

Deng, L., Liang, H. L., Burnette, B., Beckett, M., Darga, T. E., Weichselbaum, R. R., & Fu, Y. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,101 · see citing works

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y. J., Yuan, J. D., Kitano, S., Mu, Z., Rasalan, T. S., Adamow, M. J., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,087 · see citing works

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072 · see citing works

A cytokine-mediated link between innate immunity, inflammation, and cancer

Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940 · see citing works

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860 · see citing works

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,678 · see citing works

Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody

Dewan, M. Z., Galloway, A. E., Kawashima, N., Dewyngaert, J. K., Babb, J. S., Formenti, S. C., & Demaria, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0265 · Cited by 1,678 · see citing works

Normalization of the Vasculature for Treatment of Cancer and Other Diseases

Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605 · see citing works

Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis

Garcı́a-Barros, M., Paris, F., Cordon‐Cardo, C., Lyden, D. C., Rafii, S., Haimovitz‐Friedman, A., FUKS, Z. Y., & Kolesnick, R. (2003) · Science · doi:10.1126/science.1082504 · Cited by 1,591 · see citing works

VEGF and the quest for tumour angiogenesis factors

Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536 · see citing works

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

Sekulić, A., Migden, M. R., Oro, A. E., Dirix, L. Y., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S. S., Arron, S. T., Friedlander, P. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113713 · Cited by 1,460 · see citing works

Oncolytic virotherapy

Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428 · see citing works

Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection

Wherry, E. J., Ha, S., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,355 · see citing works

Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice

Paris, F., FUKS, Z. Y., Kang, A. D., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz‐Friedman, A., Cordon‐Cardo, C., & Kolesnick, R. (2001) · Science · doi:10.1126/science.1060191 · Cited by 1,281 · see citing works

Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors

Goumans, M., Valdimarsdóttir, G., Itoh, S., Rosendahl, A., Sideras, P., & ten Dijke, P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1743 · Cited by 1,127 · see citing works

Strategies to improve radiotherapy with targeted drugs

Begg, A. C., Stewart, F. A., & Vens, C. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3007 · Cited by 1,115 · see citing works

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

Brizel, D. M., Sibley, G. S., Prosnitz, L. R., Scher, R. L., & Dewhirst, M. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00101-6 · Cited by 1,068 · see citing works

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052 · see citing works

Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer

Demaria, S., Kawashima, N., Yang, A. M., Devitt, M. L., Babb, J. S., Allison, J. P., & Formenti, S. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.728.11.2 · Cited by 1,016 · see citing works

Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors

Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996 · see citing works

Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas

Zeng, J., See, A. P., Phallen, J., Jackson, C. M., Belcaid, Z., Ruzevick, J., Durham, N., Meyer, C., Harris, T. J., Albesiano, E., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.12.025 · Cited by 889 · see citing works

Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy

Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F.-F., O'Sullivan, B., He, Z., Peng, Y., Tan, A.-C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2385 · Cited by 886 · see citing works

The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive Immunity

Burnette, B., Liang, H. L., Lee, Y., Chlewicki, L. K., Khodarev, N. N., Weichselbaum, R. R., Fu, Y., & Auh, S. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2820 · Cited by 883 · see citing works

Tumor-infiltrating NY-ESO-1–specific CD8 ⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

Matsuzaki, J., Gnjatic, S., Mhawech-Fauceglia, P., Beck, A., Miller, A., Tsuji, T., Eppolito, C., Qian, F., Lele, S., Shrikant, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003345107 · Cited by 859 · see citing works

Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts

Kojima, Y., Acar, A., Eaton, E. N., Mellody, K. T., Scheel, C., Ben‐Porath, I., Önder, T. T., Wang, Z. C., Richardson, A. L., Weinberg, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013805107 · Cited by 851 · see citing works

Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients

Baitsch, L., Baumgaertner, P., Devêvre, E., Raghav, S. K., Legat, A., Barba, L., Wieckowski, S., Bouzourene, H., Deplancke, B., Romero, P., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46102 · Cited by 845 · see citing works

Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression

Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004992 · Cited by 807 · see citing works

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice

Kioi, M., Vogel, H. S., Schultz, G. M., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40283 · Cited by 775 · see citing works

Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells

Matsumura, S., Wang, B., Kawashima, N., Braunstein, S. E., Badura, M. L., Cameron, T. O., Babb, J. S., Schneider, R. J., Formenti, S. C., Dustin, M. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3099 · Cited by 711 · see citing works

Tumor microenvironment: The role of the tumor stroma in cancer

Li, H., Fan, X., & Houghton, J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21159 · Cited by 646 · see citing works

Inflammation as a Tumor Promoter in Cancer Induction

Philip, M., Rowley, D. A., & Schreiber, H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.006 · Cited by 640 · see citing works

Multifunctional Albumin–MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and Enhance Radiation Response

Prasad, P., Gordijo, C. R., Abbasi, A. Z., Maeda, A., Ip, A., Rauth, A. M., DaCosta, R. S., & Wu, X. Y. (2014) · ACS Nano · doi:10.1021/nn405773r · Cited by 632 · see citing works

Immunostimulatory monoclonal antibodies for cancer therapy

Melero, I., Hervás‐Stubbs, S., Glennie, M. J., Pardoll, D. M., & Chen, L. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2051 · Cited by 626 · see citing works

Pathogenetic mechanisms in radiation fibrosis

Yarnold, J. R., & Vozenin, M. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.09.002 · Cited by 624 · see citing works

Targeting the TGFβ pathway for cancer therapy

Neuzillet, C., Tijeras‐Raballand, A., Cohen, R., Cros, J. F., Faivre, S. J., Raymond, É., & Gramont, A. D. E. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.001 · Cited by 610 · see citing works

Untitled work

(2001) · PubMed · Cited by 605 · see citing works

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85

Overgaard, J., Hansen, H. S., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindeløv, B., & Jørgensen, K. J. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00220-x · Cited by 575 · see citing works

A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor

Hu, J. C. C., Coffin, R. S., Davis, C. J., Graham, N. J., Groves, N., GUEST, P. J., Harrington, K. J., James, N. D., Love, C., McNeish, I. A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0759 · Cited by 571 · see citing works

Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS)

Park, H. J., Griffin, R. J., Hui, S. K., Levitt, S. H., & Song, C. W. (2012) · Radiation Research · doi:10.1667/rr2773.1 · Cited by 550 · see citing works

Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells.

Barcellos‐Hoff, M. H., & Ravani, S. A. (2000) · PubMed · Cited by 536 · see citing works

Tumour immunity: effector response to tumour and role of the microenvironment

Mantovani, A., Romero, P. J., Palucka, A. K., & Marincola, F. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60241-x · Cited by 536 · see citing works

Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation

Brown, J. M. (1979) · British Journal of Radiology · doi:10.1259/0007-1285-52-620-650 · Cited by 527 · see citing works

Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer

Bailey, J. M., Swanson, B. J., Hamada, T., Eggers, J. P., Singh, P. K., Caffrey, T. C., Ouellette, M. M., & Hollingsworth, M. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0291 · Cited by 520 · see citing works

Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia.

Rønnov‐Jessen, L., & PETERSEN, O. W. (1993) · PubMed · Cited by 514 · see citing works

Radiation and the microenvironment – tumorigenesis and therapy

Barcellos‐Hoff, M. H., Park, C., & Wright, E. G. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1735 · Cited by 513 · see citing works

Transforming growth factor-β and fibrosis

Verrecchia, F., & Mauviel, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i22.3056 · Cited by 512 · see citing works

Hypoxic Modification of Radiotherapy in Squamous Cell Carcinoma of the Head and Neck - A Systematic Review and Meta-Analysis

Overgaard, J. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.03.004 · Cited by 456 · see citing works

Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation

Gupta, A. K., Probst, H. C., Vuong, V., Landshammer, A., Muth, S., Yagita∥, H., Schwendener, R. A., Pruschy, M. N., Knuth, A. K., & van den Broek, M. F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200563 · Cited by 446 · see citing works

Radiation Enhances Regulatory T Cell Representation

Kachikwu, E. L., Iwamoto, K. S., Liao, Y., DeMarco, J. J., Agazaryan, N., Economou, J. S., McBride, W. H., & Schaue, D. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.09.034 · Cited by 429 · see citing works

Transforming growth factor-beta activation in irradiated murine mammary gland.

Barcellos‐Hoff, M. H., Derynck, R., Tsang, M., & Weatherbee, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117045 · Cited by 428 · see citing works

Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment

Augsten, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00062 · Cited by 427 · see citing works

Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress

Martins, I., Kepp, O., Schlemmer, F., Adjemian, S., Tailler, M., Shen, S., Michaud, M., Menger, L., Gdoura, A., Tajeddine, N., et al. (2010) · Oncogene · doi:10.1038/onc.2010.500 · Cited by 414 · see citing works

The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response

Stamell, E. F., Wolchok, J. D., Gnjatic, S., Lee, N. Y., & Brownell, I. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.03.017 · Cited by 387 · see citing works

Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis

Chaudhary, N. I., Roth, G. J., Hilberg, F., Müller–Quernheim, J., Prasse, A., Zissel, G., Schnapp, A., & Park, J. E. (2007) · European Respiratory Journal · doi:10.1183/09031936.00152106 · Cited by 386 · see citing works

Radiation to Stromal Fibroblasts Increases Invasiveness of Pancreatic Cancer Cells through Tumor-Stromal Interactions

Ohuchida, K., Mizumoto, K., Murakami, M., Qian, L.-W., Sato, N., Nagai, E., Matsumoto, K., Nakamura, T., & Tanaka, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2464 · Cited by 385 · see citing works

Combining radiotherapy and immunotherapy: A revived partnership

Demaria, S., Bhardwaj, N., McBride, W. H., & Formenti, S. C. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.06.032 · Cited by 375 · see citing works

Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma

Kidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., Andreeff, M., & Marini, F. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030563 · Cited by 371 · see citing works

Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer

Gulley, J. L., Arlen, P. M., Bastian, A., Morin, S., Marté, J. L., Beetham, P. K., Tsang, K.-Y., Yokokawa, J., Hodge, J. W., Ménard, C. M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2062 · Cited by 370 · see citing works

Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.

Gutheil, J. C., Campbell, T. N., Pierce, P. R., Watkins, J. D., Huse, W. D., Bodkin, D., & Cheresh, D. A. (2000) · PubMed · Cited by 369 · see citing works

Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer

Bacco, F. D., Luraghi, P., Médico, E., Reato, G., Girolami, F., Perera, T. P. S., Gabriele, P., Comoglio, P. M., & Boccaccio, C. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr093 · Cited by 364 · see citing works

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer

Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Simopoulos, C., Turley, H., Talks, K., Gatter, K. C., & Harris, A. L. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02848-1 · Cited by 361 · see citing works

Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression

Biswas, S., Guix, M., Rinehart, C., Dugger, T. C., Chytil, A. M., Moses, H. L., Freeman, M. L., & Arteaga, C. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30740 · Cited by 346 · see citing works

Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans

Omenetti, A., Porrello, A., Jung, Y., Yang, L., Popov, Y. V., Choi, S. S., Witek, R. P., Alpini, G. D., Venter, J., VanDongen, H. M. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35875 · Cited by 342 · see citing works

Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma.

Löhr, M. J., Schmidt, C., Ringel, J., Kluth, M., Müller, P., Nizze, H., & Jesnowski, R. (2001) · PubMed · Cited by 323 · see citing works

Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses

Seung, S. K., Curti, B. D., Crittenden, M. R., Walker, E., Coffey, T. S., Siebert, J., Miller, W. L., Payne, R., Glenn, L. A., Bageac, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003649 · Cited by 303 · see citing works

Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial

Koukourakis, M. I., Bentzen, S. M., Giatromanolaki, A., Wilson, G. D., Daley, F. M., Saunders, M. I., Dische, S., Sivridis, E., & Harris, A. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7474 · Cited by 289 · see citing works

Scheduling of Radiation with Angiogenesis Inhibitors Anginex and Avastin Improves Therapeutic Outcome via Vessel Normalization

Dings, R. P. M., Loren, M. L., Heun‐Johnson, H., McNiel, E. A., Griffioen, A. W., Mayo, K. H., & Griffin, R. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2441 · Cited by 287 · see citing works

Ionizing Radiation Accelerates the Development of Atherosclerotic Lesions in ApoE−/− Mice and Predisposes to an Inflammatory Plaque Phenotype Prone to Hemorrhage

Stewart, F. A., Heeneman, S., Poele, J. A. M. T., Kruse, J. J. C. M., Russell, N. S., Gijbels, M. J., & Daemen, M. J. A. P. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050409 · Cited by 286 · see citing works

Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local Irradiation

Kozin, S. V., Kamoun, W. S., Huang, Y., Dawson, M., Jain, R. K., & Duda, D. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4446 · Cited by 278 · see citing works

Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis

Ohba, K., Omagari, K., Nakamura, T., Ikuno, N., Saeki, S., Matsuo, I., Kinoshita, H., Masuda, J., Hazama, H., Sakamoto, I., et al. (1998) · Gut · doi:10.1136/gut.43.4.575 · Cited by 277 · see citing works

Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies

Verbrugge, I., Hagekyriakou, J., Sharp, L. L., Gallí, M., West, A. C., McLaughlin, N. M., Duret, H., Yagita∥, H., Johnstone, R. W., Smyth, M. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0210 · Cited by 275 · see citing works

Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases

Gressner, O. A., & Gressner, A. M. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01826.x · Cited by 272 · see citing works

Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis

Puthawala, K., Hadjiangelis, N., Jacoby, S. C., Bayongan, E., Zhao, Z., Yang, Z., Devitt, M. L., Horan, G. S., Weinreb, P. H., Lukashev, M. E., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-806oc · Cited by 272 · see citing works

Inflammation-associated cancer: NF-κB is the lynchpin

Li, Q., Withoff, S., & Verma, I. M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.003 · Cited by 268 · see citing works

Targeting HER-2/ neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion

Czerniecki, B. J., Koski, G. K., Koldovsky, U., Xu, S., Cohen, P. A., Mick, R., Nisenbaum, H. L., Pasha, T., Xu, M., Fox, K. R., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4038 · Cited by 267 · see citing works

Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck

Harrington, K. J., Hingorani, M., Tanay, M. A., Hickey, J., Bhide, S. A., Clarke, P. M., Renouf, L. C., Thway, K., Sibtain, A., McNeish, I. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0196 · Cited by 259 · see citing works

Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial

Janssens, G. O. R. J., Rademakers, S. E., Terhaard, C. H. J., Doornaert, P., Bijl, H. P., van den Ende, P. L. A., Chin, A., Marres, H. A. M., de Bree, R., van der Kogel, A. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.9315 · Cited by 259 · see citing works

The Response of the Microvascular System to Radiation: A Review

Baker, D. G., & Krochak, R. J. (1989) · Cancer Investigation · doi:10.3109/07357908909039849 · Cited by 258 · see citing works

Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly Diagnosed Malignant Gliomas

Reardon, D. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1389 · Cited by 257 · see citing works

A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy

Hiniker, S. M., Chen, D. S., Reddy, S. A., Chang, D. T., Jones, J. C., Mollick, J. A., Swetter, S. M., & Knox, S. J. (2012) · Translational Oncology · doi:10.1593/tlo.12280 · Cited by 248 · see citing works

Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells

Ling, Y., Yang, Y., Lu, N., You, Q., Wang, S., Gao, Y., Chen, Y., & Guo, Q. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.155 · Cited by 246 · see citing works

Significance of Heparanase in Cancer and Inflammation

Vlodavsky, I., Beckhove, P., Lerner, I., Pisano, C., Meirovitz, A., Ilan, N., & Elkin, M. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0082-7 · Cited by 240 · see citing works

TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo

Bouquet, F., Pal, A., Pilones, K. A., Demaria, S., Hann, B. C., Akhurst, R. J., Babb, J. S., Lonning, S. M., DeWyngaert, J. K., Formenti, S. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0544 · Cited by 240 · see citing works

Intratumoral hypoxia, radiation resistance, and HIF-1

Semenza, G. L. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00118-7 · Cited by 235 · see citing works

Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma

Wersäll, P. J., Blomgren, H., Pisa, P., Lax, I., Kälkner, K., & Svedman, C. (2006) · Acta Oncologica · doi:10.1080/02841860600604611 · Cited by 233 · see citing works

A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors

Rodon, J. A., Tawbi, H. A.-H., Thomas, A., Stoller, R. G., Turtschi, C. P., Baselga, J. M., Sarantopoulos, J., Mahalingam, D., Shou, Y., Moles, M. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1710 · Cited by 230 · see citing works

Vascular Endothelium as the Vulnerable Element in Tumours

Denekamp, J. (1984) · Acta Radiologica Oncology · doi:10.3109/02841868409136015 · Cited by 224 · see citing works

Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma

Miyamoto, S., Inoue, H., Nakamura, T., Yamada, M., Sakamoto, C., Urata, Y., Okazaki, T., Marumoto, T., Takahashi, A., Takayama, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3185 · Cited by 222 · see citing works

β1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts

Park, C. C., Zhang, H. J., Yao, E. S., Park, C. J., & Bissell, M. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6390 · Cited by 220 · see citing works

Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress

Cui, J. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401427c · Cited by 216 · see citing works

Pancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells through β1-Integrin Signaling

Mantoni, T. S., Lunardi, S., Al‐Assar, O., Masamune, A., & Brunner, T. B. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1633 · Cited by 206 · see citing works

Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy

Abdollahi, A., Griggs, D. W., Zieher, H., Roth, A. K., Lipson, K. E., Saffrich, R., Gröne, H., Hallahan, D. E., Reisfeld, R. A., Debus, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1223 · Cited by 205 · see citing works

Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy

Wang, J., Boerma, M., Fu, Q., & Hauer‐Jensen, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i22.3047 · Cited by 202 · see citing works

Radiation, Inflammation, and Immune Responses in Cancer

Multhoff, G., & Radons, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00058 · Cited by 201 · see citing works

Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression

Laoui, D., van Overmeire, E., Baetselier, P. D., Ginderachter, J. V. V., & Raes, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00489 · Cited by 199 · see citing works

Combination of Conformal Radiotherapy and Intratumoral Injection of Adoptive Dendritic Cell Immunotherapy in Refractory Hepatoma

Chi, K., Liu, S., Li, C., Kuo, H.-P., Wang, Y., Chao, Y., & Hsieh, S. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000154248.74383.5e · Cited by 187 · see citing works

β1-Integrin: A Potential Therapeutic Target in the Battle against Cancer Recurrence

Barkan, D., & Chambers, A. F. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0642 · Cited by 181 · see citing works

Oncolytic viruses: a novel form of immunotherapy

Prestwich, R. J. D., Harrington, K. J., Pandha, H., Vile, R. G., Melcher, A. A., & Errington‐Mais, F. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.10.1581 · Cited by 180 · see citing works

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

Harrington, K. J., Billingham, L. J., Brunner, T. B., Burnet, N. G., Chan, C. S. K., Hoskin, P., Mackay, R. I., Maughan, T., Macdougall, J., McKenna, W. G., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.240 · Cited by 172 · see citing works

Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023.

Qian, L.-W., Mizumoto, K., Urashima, T., Nagai, E., Maehara, N., Sato, N., Nakajima, M., & Tanaka, M. (2002) · PubMed · Cited by 166 · see citing works

How Can We Overcome Tumor Hypoxia in Radiation Therapy?

Harada, H. (2011) · Journal of Radiation Research · doi:10.1269/jrr.11056 · Cited by 164 · see citing works

PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models

Dredge, K. S., Hammond, E., Handley, P., Gonda, T. J., Smith, M. T., Vincent, C., Brandt, R., Ferro, V., & Bytheway, I. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.11 · Cited by 163 · see citing works

Microvascular studies on the origins of perfusion-limited hypoxia.

Dewhirst, M. W., Kimura, H., Rehmus, W., Braun, R. D., Papahadjopoulos, D., Hong, K., & Secomb, T. W. (1996) · Europe PMC (PubMed Central) · Cited by 162 · see citing works

Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice

Gough, M. J., Crittenden, M. R., Sarff, M., Pang, P., Seung, S. K., Vetto, J. T., Hu, H., Redmond, W. L., Holland, J. M., & Weinberg, A. D. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181ee7095 · Cited by 159 · see citing works

Microenvironment and Radiation Therapy

Yoshimura, M., Itasaka, S., Harada, H., & Hiraoka, M. (2012) · BioMed Research International · doi:10.1155/2013/685308 · Cited by 155 · see citing works

β1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury

Cordes, N., Seidler, J. F., Durzok, R., Geinitz, H., & Brakebusch, C. (2005) · Oncogene · doi:10.1038/sj.onc.1209164 · Cited by 155 · see citing works

Radiation-induced apoptosis in microvascular endothelial cells

Langley, R. E., Bump, E. A., Quartuccio, S., Medeiros, D., & Braunhut, S. J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.119 · Cited by 153 · see citing works

Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer

Dewan, M. Z., Vanpouille‐Box, C., Kawashima, N., DiNapoli, S., Babb, J. S., Formenti, S. C., Adams, S., & Demaria, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0984 · Cited by 153 · see citing works

Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly Diagnosed Malignant Gliomas

Reardon, D. A., Akabani, G., Coleman, R. E., Friedman, A. H., Friedman, H. S., Herndon, J. E., Cokgor, I., McLendon, R. E., Pegram, C. N., Provenzale, J. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1389 · Cited by 152 · see citing works

Radiation-induced carotid artery atherosclerosis

Gujral, D. M., Chahal, N., Senior, R., Harrington, K. J., & Nutting, C. M. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.08.009 · Cited by 151 · see citing works

Single-Dose and Fractionated Irradiation Promote Initiation and Progression of Atherosclerosis and Induce an Inflammatory Plaque Phenotype in ApoE−/− Mice

Hoving, S., Heeneman, S., Gijbels, M. J., Poele, J. A. M. T., Russell, N. S., Daemen, M. J. A. P., & Stewart, F. A. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.02.031 · Cited by 149 · see citing works

The Fibroblast Integrin α11β1 Is Induced in a Mechanosensitive Manner Involving Activin A and Regulates Myofibroblast Differentiation

Carracedo, S., Lü, N., Popova, S. N., Jonsson, R., Eckes, B., & Gullberg, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078766 · Cited by 145 · see citing works

Vascular Activation of Adhesion Molecule mRNA and Cell Surface Expression by Ionizing Radiation

Heckmann, M., Douwes, K., Peter, R. U., & Degitz, K. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3826 · Cited by 138 · see citing works

Improved Intratumoral Oxygenation Through Vascular Normalization Increases Glioma Sensitivity to Ionizing Radiation

McGee, M. C., Hamner, J. B., Williams, R. F., Rosati, S. F., Sims, T. L., Ng, C. Y., Gaber, M. W., Calabrese, C. R., Wu, J., Nathwani, A. C., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.010 · Cited by 137 · see citing works

ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase

Hodkinson, P. S., Elliott, T., Wong, W. S., Rintoul, R. C., MacKinnon, A. C., Haslett, C., & Sethi, T. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401849 · Cited by 136 · see citing works

Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas

Cokgor, I., Akabani, G., Kuan, C., Friedman, H. S., Friedman, A. H., Coleman, R. E., McLendon, R. E., Bigner, S. H., Zhao, X.-G., Garcia-Turner, A. M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3862 · Cited by 136 · see citing works

Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model

Lee, M. J., Hatton, B. A., Villavicencio, E. H., Khanna, P. C., Friedman, S. D., Ditzler, S. H., Pullar, B. J., Robison, K. E., White, K., Tunkey, C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114718109 · Cited by 134 · see citing works

A safety run‐in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)

Nabors, B., Mikkelsen, T., Hegi, M. E., Ye, X., Batchelor, T. T., Lesser, G. J., Peereboom, D. M., Rosenfeld, M. R., Olsen, J., Brem, S., et al. (2012) · Cancer · doi:10.1002/cncr.27585 · Cited by 132 · see citing works

Links between Innate Immunity and Normal Tissue Radiobiology

Schaue, D., & McBride, W. H. (2010) · Radiation Research · doi:10.1667/rr1931.1 · Cited by 129 · see citing works

Dual Inhibition of the PI3K/mTOR Pathway Increases Tumor Radiosensitivity by Normalizing Tumor Vasculature

Fokas, E., Im, J. H., Hill, S. A., Yameen, S., Stratford, M. R. L., Beech, J. S., Hackl, W., Maira, S.-M., Bernhard, E. J., McKenna, W. G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2263 · Cited by 128 · see citing works

Gamma-Ray Resistance of Regulatory CD4+CD25+Foxp3+ T Cells in Mice

Qu, Y., Jin, S., Zhang, A., Zhang, B., Shi, X.-Y., Wang, J.-J., & Zhao, Y. (2010) · Radiation Research · doi:10.1667/rr0978.1 · Cited by 125 · see citing works

Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.

Lund, E. L., Bastholm, L., & Kristjansen, P. E. G. (2000) · PubMed · Cited by 125 · see citing works

Role of Radiation-induced TGF-beta Signaling in Cancer Therapy

Dancea, H. C. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.06 · Cited by 124 · see citing works

Novel insights into pathological changes in muscular arteries of radiotherapy patients

Russell, N. S., Hoving, S., Heeneman, S., Hage, J. J., Woerdeman, L. A. E., de Bree, R., Lohuis, P. J. F. M., Smeele, L. E., Cleutjens, J. P. M., Valenkamp, A., et al. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.05.021 · Cited by 121 · see citing works

Suramin: Clinical Uses and Structure-Activity Relationships

McGeary, R. P., Bennett, A. J., Tran, Q., Cosgrove, K. L., & Ross, B. P. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708786369573 · Cited by 119 · see citing works

Combination of External Beam Radiotherapy (EBRT) With Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients

Finkelstein, S. E., Iclozan, C., Bui, M. M., Cotter, M. J., Ramakrishnan, R., Ahmed, J., Noyes, D. R., Cheong, D., González, R., Heysek, R. V., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.12.068 · Cited by 115 · see citing works

Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma

Kim, Y. H., Girardi, M., Duvic, M. A., Kuzel, T. M., Link, B. K., Pinter‐Brown, L. C., & Rook, A. H. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.12.052 · Cited by 115 · see citing works

A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost

Reardon, D. A., Zalutsky, M. R., Akabani, G., Coleman, R. E., Friedman, A. H., Herndon, J. E., McLendon, R. E., Pegram, C. N., Quinn, J. A., Rich, J. N., et al. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-053 · Cited by 112 · see citing works

Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced

Hellevik, T., Pettersen, I., Berg, V., Winberg, J., Moe, B. T., Bartnes, K., Paulssen, R. H., Busund, L., Bremnes, R. M., Chalmers, A. J., et al. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-59 · Cited by 112 · see citing works

The influence of microenvironmental factors during cancer therapy.

Durand, R. E. (1995) · PubMed · Cited by 112 · see citing works

IL-13 Induces Connective Tissue Growth Factor in Rat Hepatic Stellate Cells via TGF-β–Independent Smad Signaling

Liu, Y., Meyer, C., Müller, A., Herweck, F., Li, Q., Müllenbach, R., Mertens, P. R., Dooley, S., & Weng, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003260 · Cited by 111 · see citing works

Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report

Okuma, K., Yamashita, H., Niibe, Y., Hayakawa, K., & Nakagawa, K. (2011) · Journal of Medical Case Reports · doi:10.1186/1752-1947-5-111 · Cited by 109 · see citing works

Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy

Brown, J. M. (2013) · British Journal of Radiology · doi:10.1259/bjr.20130686 · Cited by 107 · see citing works

Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion

Kaliski, A., Maggiorella, L., Cengel, K. A., Mathé, D., Rouffiac, V., Opolon, P., Lassau, N., Bourhis, J., & Deutsch, É. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0179 · Cited by 97 · see citing works

Combining Radiation and Molecular Targeting in Cancer Therapy

Camphausen, K., & Tofilon, P. J. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.3.544 · Cited by 93 · see citing works

Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma

Teicher, B. A., Holden, S. A., Dupuis, N. P., Kakeji, Y., Ikebe, M., Emi, Y., & Goff, D. A. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666043 · Cited by 89 · see citing works

Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas

Antoniades, J., Brady, L. W., & Lightfoot, D. A. (1977) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(77)90020-7 · Cited by 84 · see citing works

Radiotherapy augments the immune response to prostate cancer in a time‐dependent manner

Harris, T. J., Hipkiss, E. L., Borzillary, S., Wada, S., Grosso, J. F., Yen, H., Getnet, D., Bruno, T. C., Goldberg, M. V., Pardoll, D. M., et al. (2008) · The Prostate · doi:10.1002/pros.20794 · Cited by 84 · see citing works

The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology

Good, J., & Harrington, K. J. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.06.009 · Cited by 83 · see citing works

Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

Harada, H., Itasaka, S., Zhu, Y., Zeng, L., Xie, X., Morinibu, A., Shinomiya, K., & Hiraoka, M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604939 · Cited by 82 · see citing works

Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies

Distler, J. H. W., & Distler, O. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.120196 · Cited by 70 · see citing works

Oxidative Stress Promotes Ligand-independent and Enhanced Ligand-dependent Tumor Necrosis Factor Receptor Signaling

Ozsoy, H. Z., Sivasubramanian, N., Wieder, E., Pedersen, S. E., & Mann, D. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802967200 · Cited by 67 · see citing works

Role of Heparanase in Radiation-Enhanced Invasiveness of Pancreatic Carcinoma

Meirovitz, A., Hermano, E., Lerner, I., Zcharia, E., Pisano, C., Peretz, T., & Elkin, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3402 · Cited by 67 · see citing works

Low-dose radiation augments vasculogenesis signaling through HIF-1–dependent and –independent SDF-1 induction

Lerman, O. Z., Greives, M. R., Singh, S. P., Thanik, V. D., Chang, C. C., Seiser, N., Brown, D. J., Knobel, D., Schneider, R. J., Formenti, S. C., et al. (2010) · Blood · doi:10.1182/blood-2009-03-213629 · Cited by 65 · see citing works

Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues

Hammond, E., Handley, P., Dredge, K. S., & Bytheway, I. (2013) · FEBS Open Bio · doi:10.1016/j.fob.2013.07.007 · Cited by 64 · see citing works

NIMRAD – A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer

Thomson, D. J., Yang, H., Baines, H., Miles, E. A., Bolton, S., West, C., & Slevin, N. J. (2014) · Clinical Oncology · doi:10.1016/j.clon.2014.03.003 · Cited by 64 · see citing works

Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence

Liu, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11384 · Cited by 64 · see citing works

Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.

Medicherla, S., Li, L., Jing, Y., Kapoun, A. M., Gaspar, N. J., Liu, Y.-W., Mangadu, R., O’Young, G., Protter, A. A., Schreiner, G. F., et al. (2007) · PubMed · Cited by 61 · see citing works

Skin Perfusion and Oxygenation Changes in Radiation Fibrosis

Chin, M. S., Freniere, B. B., Bonney, C. F., Lancerotto, L., Saleeby, J., Lo, Y., Orgill, D. P., FitzGerald, T. J., & Lalikos, J. F. (2013) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3182818b94 · Cited by 50 · see citing works

TNP-470/minocycline/cytotoxic therapy: A systems approach to cancer therapy

Teicher, B. A., Emi, Y., Kakeji, Y., & Northey, D. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00380-2 · Cited by 50 · see citing works

Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody.

Kuwada, S. K. (2007) · PubMed · Cited by 49 · see citing works

Radiation as Immunomodulator: Implications for Dendritic Cell-Based Immunotherapy

Roses, R. E., Datta, J., & Czerniecki, B. J. (2014) · Radiation Research · doi:10.1667/rr13495.1 · Cited by 49 · see citing works

Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer

Janssens, G. O. R. J., Rademakers, S. E., Terhaard, C. H. J., Doornaert, P., Bijl, H. P., van den Ende, P. L. A., Chin, A., Takes, R. P., de Bree, R., Hoogsteen, I. J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1730 · Cited by 47 · see citing works

Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling

Kyula, J., Khan, A., Mansfield, D., Karapanagiotou, E. M., McLaughlin, M., Roulstone, V., Zaidi, S. H. H., Pencavel, T. D., Touchefeu, Y., Seth, R., et al. (2013) · Oncogene · doi:10.1038/onc.2013.112 · Cited by 43 · see citing works

IN VIVO GLIOMA GROWTH REQUIRES HOST-DERIVED MATRIX METALLOPROTEINASE 2 FOR MAINTENANCE OF ANGIOARCHITECTURE

Takahashi, M., Fukami, S., Iwata, N., Inoue, K., Itohara, S., Itoh, H., Haraoka, J., & Saido, T. C. (2002) · Pharmacological Research · doi:10.1016/s1043-6618(02)00081-6 · Cited by 43 · see citing works

Suramin and radiotherapy in newly diagnosed glioblastoma: Phase 2 NABTT CNS Consortium study

Laterra, J., Grossman, S. A., Carson, K. A., Lesser, G. J., Hochberg, F. H., & Gilbert, M. R. (2004) · Neuro-Oncology · doi:10.1215/s1152851703000127 · Cited by 43 · see citing works

Accelerated Radiotherapy, Carbogen, and Nicotinamide (ARCON) in the Treatment of Advanced Bladder Cancer: Mature Results of a Phase II Nonrandomized Study

Hoskin, P., Rojas, A., & Saunders, M. I. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.06.1950 · Cited by 42 · see citing works

Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored

de la Cruz‐Merino, L., Illescas-Vacas, A., pez, A. G.-L., Barco-Sánchez, A., & Míguez-Sánchez, C. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00102 · Cited by 40 · see citing works

Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: Experimental models and clinical perspectives

Ahn, G., & Brown, J. M. (2009) · Cell Cycle · doi:10.4161/cc.8.7.8075 · Cited by 39 · see citing works

Ad.Egr-TNF and Local Ionizing Radiation Suppress Metastases by Interferon-β-Dependent Activation of Antigen-specific CD8+ T Cells

Meng, Y., Mauceri, H. J., Khodarev, N. N., Darga, T. E., Pitroda, S. P., Beckett, M. A., Kufe, D. W., & Weichselbaum, R. R. (2010) · Molecular Therapy · doi:10.1038/mt.2010.18 · Cited by 38 · see citing works

Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: Report of an rtog prospective randomized trial

Simpson, J. R., Bauer, M., Pérez, C. A., Wasserman, T. H., Emami, B., Doggett, R. L. S., Byhardt, R. W., Phillips, T. L., & Mowry, P. A. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90953-x · Cited by 37 · see citing works

Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme

Tayel, A., Galil, K. H. A. E., Ebrahim, M., Ibrahim, A. S., El-Gayar, A. M., & Al-Gayyar, M. M. H. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.001 · Cited by 36 · see citing works

Oncolytic vaccinia virus in combination with radiation shows synergistic antitumor efficacy in pancreatic cancer

Dai, M., Liu, S. L., Chen, N. G., Zhang, T. P., You, L., Zhang, F., Chou, T., Szalay, A. A., Fong, Y., & Zhao, Y. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.007 · Cited by 32 · see citing works

Transforming growth factor-β and fibrosis

Franck, Verrecchia, Alain, & Mauviel (2007) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 31 · see citing works

Inhibition of growth factor effects in retinal pigment epithelial cells.

Leschey, K. H., Hines, J., Singer, J. H., Hackett, S. F., & Campochiaro, P. A. (1991) · PubMed · Cited by 30 · see citing works

Phase I/II Trial of Sequential Chemoradiotherapy Using a Novel Hypoxic Cell Radiosensitizer, Doranidazole (PR-350), in Patients With Locally Advanced Non–Small-Cell Lung Cancer (WJTOG-0002)

Nishimura, Y., Nakagawa, K., Takeda, K., Tanaka, M., Segawa, Y., Tsujino, K., Negoro, S., Fuwa, N., Hida, T., Kawahara, M., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.04.008 · Cited by 29 · see citing works

Radiotherapy and Toll-Like Receptor Agonists

Marabelle, A., Filatenkov, A., Sagiv-Barfi, I., & Kohrt, H. E. K. (2014) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2014.07.006 · Cited by 27 · see citing works

Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway

Catteau, X., Simon, P., & Noël, J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-499 · Cited by 27 · see citing works

Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models

Zhou, J., Wang, L., Xu, X., Tu, Y., Qin, S., & Yin, Y. (2012) · Oncology Letters · doi:10.3892/ol.2012.856 · Cited by 26 · see citing works

VEGF Regulates Region-Specific Localization of Perivascular Bone Marrow–Derived Cells in Glioblastoma

Burrell, K. E., Singh, S., Jalali, S., Hill, R. P., & Zadeh, G. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3119 · Cited by 26 · see citing works

ヘッジホッグ経路阻害剤,サリデギブ(IPI-926)はマウス髄芽腫モデルで寿命を延長する

Michelle, J. L., Beryl, A. H., Elisabeth, H. V., Paritosh, C. K., Seth, D. F., Ditzler, S. H., Pullar, B. J., Keith, R., Kerry, F. W., Tunkey, C., et al. (2012) · Cited by 22 · see citing works

Nintedanib (BIBF 1120) for IPF: a tomorrow therapy?

Antoniu, S. A. (2012) · Multidisciplinary Respiratory Medicine · doi:10.1186/2049-6958-7-41 · Cited by 19 · see citing works

The treatment of hepatic metastases from colorectal cancer with radiation therapy alone or combined with chemotherapy or misonidazole

Minsky, B. D., & Leibel, S. A. (1989) · Cancer Treatment Reviews · doi:10.1016/0305-7372(89)90042-x · Cited by 15 · see citing works

Endostar combined with radiotherapy increases radiation sensitivity by decreasing the expression of TGF-β1, HIF-1α and bFGF

Wu, Y.-G., Zheng, Y., Shen, Z., Ge, W., Xie, Y.-S., & Li, C. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1526 · Cited by 15 · see citing works

Positive clinical experience with misonidazole in brachytherapy and external radiotherapy

Baillet, F., Housset, M., Dessard-Diana, B., & Boisserie, G. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90919-x · Cited by 12 · see citing works

Abrogation of TGF-β by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin

Riedel, V. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000045 · Cited by 9 · see citing works

Treatment of margin positive basal cell carcinoma with vismodegib: case report and consideration of treatment options and their implications.

Bayers, S., Kapp, D. L., Beer, K. R., & Slavin, B. R. (2013) · PubMed · Cited by 8 · see citing works

Pilot Trial of Radiation Therapy and GM-CSF in Metastatic Cancer: Abscopal Responses

Formenti, S. C., Adams, S., Friedman, K. P., Fenton-Kerimian, M., Donach, M. E., Goldberg, J. D., & Demaria, S. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.07.461 · Cited by 6 · see citing works

Inflammation and tumor progression: signaling pathways and targeted intervention

Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,907 · see citing works

Reactive Oxygen Species (ROS)-Based Nanomedicine

Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,453 · see citing works

Targeting macrophages: therapeutic approaches in cancer

Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,057 · see citing works

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586 · see citing works

Mitotic progression following DNA damage enables pattern recognition within micronuclei

Harding, S. M., Benci, J. L., Irianto, J., Discher, D. E., Minn, A. J., & Greenberg, R. A. (2017) · Nature · doi:10.1038/nature23470 · Cited by 1,508 · see citing works

Using immunotherapy to boost the abscopal effect

Ngwa, W., Irabor, O. C., Schoenfeld, J. D., Hesser, J., Demaria, S., & Formenti, S. C. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2018.6 · Cited by 1,260 · see citing works

Tumor targeting via EPR: Strategies to enhance patient responses

Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262 · see citing works

Radiotherapy and immunotherapy: a beneficial liaison?

Weichselbaum, R. R., Liang, H. L., Deng, L., & Fu, Y. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.211 · Cited by 1,073 · see citing works

A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer

Braicu, C., Buse, M., Busuioc, C. I., Drulă, R., Gulei, D., Ráduly, L., Alexandru Vasile, R. U. S. U., Irimie, A., Atanasov, A. G., Slaby, O., et al. (2019) · Cancers · doi:10.3390/cancers11101618 · Cited by 940 · see citing works

Combination cancer immunotherapies tailored to the tumour microenvironment

Smyth, M. J., Ngiow, S. F., Ribas, A., & Teng, M. W. L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.209 · Cited by 944 · see citing works

Microbiota: a key orchestrator of cancer therapy

Roy, S., & Trinchieri, G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.13 · Cited by 883 · see citing works

Inflammatory microenvironment remodelling by tumour cells after radiotherapy

McLaughlin, M., Patin, E. C., Pedersen, M., Wilkins, A. C., Dillon, M. T., Melcher, A. A., & Harrington, K. J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0246-1 · Cited by 901 · see citing works

Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements

Her, S., Jaffray, D. A., & Allen, C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.012 · Cited by 865 · see citing works

Turning cold tumors into hot tumors by improving T-cell infiltration

Liu, Y., & Sun, Z. (2021) · Theranostics · doi:10.7150/thno.58390 · Cited by 836 · see citing works

Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy

Song, G., Cheng, L., Chao, Y., Yang, K., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201700996 · Cited by 777 · see citing works

Emerging combination strategies with phototherapy in cancer nanomedicine

Xie, Z., Fan, T., An, J., Choi, W., Duo, Y., Ge, Y., Zhang, B., Nie, G., Xie, N., Zheng, T., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00215a · Cited by 718 · see citing works

Cold and hot tumors: from molecular mechanisms to targeted therapy

Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 751 · see citing works

Radiotherapy combined with immunotherapy: the dawn of cancer treatment

Zhang, Z., Liu, X., Chen, D., & Yu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01102-y · Cited by 695 · see citing works

Challenges and Opportunities for Pancreatic Cancer Immunotherapy

Bear, A. S., Vonderheide, R. H., & O'Hara, M. H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.08.004 · Cited by 674 · see citing works

Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment

Subhan, M. A., Yalamarty, S. S. K., Filipczak, N., Parveen, F., & Torchilin, V. P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060571 · Cited by 623 · see citing works

Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy

Lu, K., He, C., Guo, N., Chan, C., Ni, K., Lan, G., Tang, H., Pelizzari, C. A., Fu, Y., Spiotto, M. T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0203-4 · Cited by 602 · see citing works

Cancer-associated fibroblasts in gastrointestinal cancer

Kobayashi, H., Enomoto, A., Woods, S. L., Burt, A. D., Takahashi, M., & Worthley, D. L. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0115-0 · Cited by 596 · see citing works

Multidimensional communication in the microenvirons of glioblastoma

Broekman, M. L. D., Maas, S. L. N., Abels, E. R., Mempel, T. R., Krichevsky, A. M., & Breakefield, X. O. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0025-8 · Cited by 574 · see citing works

Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation

Lee, S. Y., Jeong, E. K., Ju, M. K., Jeon, H. M., Kim, M. Y., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0577-4 · Cited by 579 · see citing works

Cancer Radiosensitizers

Wang, H., Mu, X., He, H., & Zhang, X. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.003 · Cited by 579 · see citing works

2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents

Pająk, B., SİWİAK, E., Sołtyka, M., Priebe, A. M., Zielinski, R. J., Fokt, I., Ziemniak, M., Jaśkiewicz, A., Borowski, R., Domoradzki, T., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010234 · Cited by 574 · see citing works

Current advance of nanotechnology in diagnosis and treatment for malignant tumors

Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 604 · see citing works

Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy

Jarosz–Biej, M., Smolarczyk, R., Cichoń, T., & Kułach, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133212 · Cited by 549 · see citing works

Clinical update on head and neck cancer: molecular biology and ongoing challenges

Alsahafi, E., Begg, K., Amelio, I., Raulf, N., Lucarelli, P., Sauter, T., & Tavassoli, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1769-9 · Cited by 531 · see citing works

Molecular mechanisms of tumor resistance to radiotherapy

Wu, Y., Song, Y., Wang, R., & Wang, T. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01801-2 · Cited by 539 · see citing works

Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

Lan, Y., Zhang, D., Xu, C., Hance, K. W., Marelli, B., Qi, J., Yu, H., Qin, G., Sircar, A., Hernández, V. M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan5488 · Cited by 494 · see citing works

Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses

Chao, Y., Xu, L., Liang, C., Feng, L., Xu, J., Dong, Z., Tian, L., Yi, X., Yang, K., & Liu, Z. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0262-6 · Cited by 493 · see citing works

Charged-particle therapy in cancer: clinical uses and future perspectives

Durante, M., Orecchia, R., & Loeffler, J. S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.30 · Cited by 491 · see citing works

Application of Radiosensitizers in Cancer Radiotherapy

Gong, L., Zhang, Y., Liu, C., Zhang, M., & Han, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s290438 · Cited by 484 · see citing works

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment

Myers, K. V., Amend, S. R., & Pienta, K. J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1022-2 · Cited by 482 · see citing works

Ketogenic diet in the treatment of cancer – Where do we stand?

Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.026 · Cited by 464 · see citing works

Role of tumor microenvironment in cancer progression and therapeutic strategy

Wang, Q., Shao, X., Zhang, Y., Zhu, M., Wang, F. X. C., Mu, J., Li, J., Yao, H., & Chen, K. (2023) · Cancer Medicine · doi:10.1002/cam4.5698 · Cited by 462 · see citing works

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Liu, Y., Dong, Y., Kong, L., Shi, F., Zhu, H., & Yu, J. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0647-8 · Cited by 450 · see citing works

Nanoscale metal−organic frameworks for combined photodynamic & radiation therapy in cancer treatment

Liu, J., Yang, Y. P., Zhu, W., Yi, X., Dong, Z., Xu, X., Chen, M., Yang, K., Lu, G. M., Jiang, L., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.034 · Cited by 447 · see citing works

Targeting non-coding RNAs to overcome cancer therapy resistance

Chen, B., Dragomir, M. P., Chen, Y., Li, Q., Horst, D. A., & Călin, G. A. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00975-3 · Cited by 442 · see citing works

Drug repurposing for cancer therapy

Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443 · see citing works

Tumor Microenvironment and Differential Responses to Therapy

Hirata, E., & Sahai, E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026781 · Cited by 422 · see citing works

Recent advances in nanomaterial-based synergistic combination cancer immunotherapy

Sang, W., Zhang, Z., Dai, Y., & Chen, X. S. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00896e · Cited by 408 · see citing works

Reactive Oxygen Species‐Regulating Strategies Based on Nanomaterials for Disease Treatment

Zhang, C., Wang, X., Du, J., Gu, Z., & Zhao, Y. (2020) · Advanced Science · doi:10.1002/advs.202002797 · Cited by 404 · see citing works

X-ray-activated nanosystems for theranostic applications

Chen, X., Song, J., Chen, X. S., & Yang, H. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00921j · Cited by 401 · see citing works

Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging

Ouyang, J., Xie, A., Zhou, J. M., Liu, R., Wang, L., Liu, H., Kong, N., & Tao, W. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01148k · Cited by 387 · see citing works

Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment

Park, J., Choi, Y., Chang, H., Um, W., Ryu, J. H., & Kwon, I. C. (2019) · Theranostics · doi:10.7150/thno.37198 · Cited by 385 · see citing works

The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics

Prakash, J., & Shaked, Y. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0002 · Cited by 391 · see citing works

Radiation-Induced Lung Injury (RILI)

Giuranno, L., Ient, J., Ruysscher, D. D., & Vooijs, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00877 · Cited by 377 · see citing works

Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions

Wang, Y., Deng, W., Li, N., Neri, S., Sharma, A., Jiang, W., & Lin, S. H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00185 · Cited by 376 · see citing works

Improving radiotherapy in cancer treatment: Promises and challenges

Chen, H. H. W., & Kuo, M. T. (2017) · Oncotarget · doi:10.18632/oncotarget.18409 · Cited by 376 · see citing works

Radiotherapy: Changing the Game in Immunotherapy

Demaria, S., Coleman, C. N., & Formenti, S. C. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.05.002 · Cited by 367 · see citing works

Immunomodulatory Nanosystems

Feng, X.-R., Xu, W.-G., Li, Z., Song, W.-T., Ding, J.-X., & Chen, X.-S. (2019) · Advancement of science · doi:10.1002/advs.201900101 · Cited by 294 · see citing works

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy

Guo, L., Tian, Y., & Zhu, W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.576946 · Cited by 358 · see citing works

Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer

Nicolas, A. M., Pesic, M., Engel, E., Ziegler, P. K., Diefenhardt, M., Kennel, K. B., Buettner, F., Conche, C., Petrocelli, V., Elwakeel, E., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.01.004 · Cited by 349 · see citing works

The Oral Microbiome and Cancer

Irfan, M., Delgado, R. Z. R., & Frias-Lopez, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.591088 · Cited by 341 · see citing works

Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy

Marciscano, A. E. E., Ghasemzadeh, A., Nirschl, T. R., Theodros, D., Kochel, C. M., Francica, B. J., Muroyama, Y., Anders, R. A., Sharabi, A. B., Velarde, E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3427 · Cited by 342 · see citing works

Synthesis of BSA‐Coated BiOI@Bi 2 S 3 Semiconductor Heterojunction Nanoparticles and Their Applications for Radio/Photodynamic/Photothermal Synergistic Therapy of Tumor

Guo, Z. J., Zhu, S., Yong, Y., Zhang, X., Dong, X., Du, J., Xie, J., Wang, Q., Gu, Z., & Zhao, Y. (2017) · Advanced Materials · doi:10.1002/adma.201704136 · Cited by 327 · see citing works

Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance

Akkari, L., Bowman, R. L., Tessier, J., Klemm, F., Handgraaf, S. M., de Groot, M. H. P., Quail, D. F., Tillard, L., Gadiot, J., Huse, J. T., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw7843 · Cited by 317 · see citing works

<p>Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy</p>

Chen, Y., Yang, J., Fu, S., & Wu, J. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s272902 · Cited by 319 · see citing works

Clinical development of new drug–radiotherapy combinations

on behalf of the NCRI CTRad Academia-Pharma Joint Working Group, Sharma, R. A., Plummer, R., Stock, J. K., Greenhalgh, T. A., Ataman, Ö., Kelly, S. J., Clay, R., Adams, R., Baird, R. D., et al. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.79 · Cited by 322 · see citing works

PD-1/PD-L1 and immunotherapy for pancreatic cancer

Feng, M., Xiong, G., Cao, Z., Yang, G., Zheng, S., Song, X., You, L., Zheng, L., Zhang, T., & Zhao, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.006 · Cited by 315 · see citing works

Enhanced Ferroptosis by Oxygen-Boosted Phototherapy Based on a 2-in-1 Nanoplatform of Ferrous Hemoglobin for Tumor Synergistic Therapy

Xu, T., Ma, Y., Yuan, Q., Hu, H., Hu, X., Qian, Z., Rolle, J. K., Gu, Y., & Li, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b09426 · Cited by 316 · see citing works

Enhanced Chemodynamic Therapy by Cu–Fe Peroxide Nanoparticles: Tumor Microenvironment-Mediated Synergistic Fenton Reaction

Koo, S., Park, O. K., Kim, J., Han, S. I., Yoo, T. Y., Lee, N., Kim, Y. G., Kim, H., Lim, C., Bae, J., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c09171 · Cited by 316 · see citing works

Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies

Koyama, S., & Nishikawa, H. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002591 · Cited by 307 · see citing works

Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer

Gong, X., Li, X., Jiang, T., Xie, H., Zhu, Z., Zhou, F., & Zhou, C. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.04.014 · Cited by 299 · see citing works

The chemistry and applications of hafnium and cerium( iv ) metal–organic frameworks

Hu, Z., Wang, Y., & Zhao, D. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00920b · Cited by 300 · see citing works

Controlling the biodistribution and clearance of nanomedicines

Cabral, H., Li, J., Miyata, K., & Kataoka, K. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00138-1 · Cited by 303 · see citing works

Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses

Chen, Q., Chen, M., & Liu, Z. (2019) · Chemical Society Reviews · doi:10.1039/c9cs00271e · Cited by 289 · see citing works

Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression

Sattiraju, A., Kang, S., Giotti, B., Chen, Z., Marallano, V. J., Brusco, C., Ramakrishnan, A., Shen, L., Tsankov, A. M., Hambardzumyan, D., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.017 · Cited by 289 · see citing works

Engineered algae: A novel oxygen-generating system for effective treatment of hypoxic cancer

Qiao, Y., Yang, F., Xie, T., Du, Z. H., Zhong, D., Qi, Y., Li, Y., Li, W., Lu, Z., Rao, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba5996 · Cited by 286 · see citing works

The genomic landscape of breast cancer and its interaction with host immunity

Luen, S. J., Virassamy, B., Savas, P. S., Salgado, R., & Loi, S. (2016) · The Breast · doi:10.1016/j.breast.2016.07.015 · Cited by 273 · see citing works

Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer

Yang, X., Lu, Y., Hang, J., Zhang, J., Zhang, T., Huo, Y., Liu, J., Lai, S., Luo, D., Wang, L., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0111 · Cited by 278 · see citing works

Coordination-Driven Self-Assembly Strategy-Activated Cu Single-Atom Nanozymes for Catalytic Tumor-Specific Therapy

Zhou, J., Xu, D., Tian, G., He, Q., Zhang, X., Liao, J. P., Mei, L., Chen, L., Gao, L., Zhao, L., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c13597 · Cited by 276 · see citing works

Carbon Ion Radiobiology

Tinganelli, W., & Durante, M. (2020) · Cancers · doi:10.3390/cancers12103022 · Cited by 271 · see citing works

Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress

Huang, Z., Wang, Y., Yao, D., Wu, J., Hu, Y., & Yuan, A. (2021) · Nature Communications · doi:10.1038/s41467-020-20243-8 · Cited by 273 · see citing works

Angiogenesis as a hallmark of solid tumors - clinical perspectives

Majidpoor, J., & Mortezaee, K. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00602-3 · Cited by 271 · see citing works

Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects

Meng, L., Cheng, Y., Tong, X., Gan, S., Ding, Y., Zhang, Y., Wang, C., Xu, L., Zhu, Y., Wu, J., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b03590 · Cited by 269 · see citing works

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy

Sánchez-Paulete, A. R., Teijeira, Á., Cueto, F. J., Garasa, S., Perez‐Gracia, J. L., Sánchez-Arráez, Á., Sancho, D., & Melero, I. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx237 · Cited by 267 · see citing works

Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome

Salem, A., Asselin, M., Reymen, B. J. T., Jackson, A., Lambin, P., West, C., O’Connor, J. P. B., & Finn, C. F. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx160 · Cited by 267 · see citing works

Challenges in developing personalized neoantigen cancer vaccines

Katsikis, P. D., Ishii, K. J., & Schliehe, C. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00937-y · Cited by 265 · see citing works

Immunomodulation by radiotherapy in tumour control and normal tissue toxicity

Cytlak, U., Dyer, D. P., Honeychurch, J., Williams, K. J., Travis, M. A., & Illidge, T. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00568-1 · Cited by 262 · see citing works

Molecular imaging of the tumor microenvironment

Zhou, Z., & Lu, Z.-R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.012 · Cited by 253 · see citing works

Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care

Hartshorn, C. M., Bradbury, M. S., Lanza, G. M., Nel, A. E., Rao, J., Wang, A. Z., Wiesner, U. B., Yang, L. P. H., & Grodzinski, P. A. (2017) · ACS Nano · doi:10.1021/acsnano.7b05108 · Cited by 263 · see citing works

Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy

Yang, W., Zhang, F., Deng, H., Lin, L., Wang, S., Kang, F., Yu, G., Lau, J., Tian, R., Zhang, M., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b07212 · Cited by 254 · see citing works

Biomaterials tools to modulate the tumour microenvironment in immunotherapy

Chao, Y., & Liu, Z. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00004-6 · Cited by 262 · see citing works

YTHDF2 inhibition potentiates radiotherapy antitumor efficacy

Wang, L., Dou, X., Chen, S., Yu, X., Huang, X., Zhang, L., Chen, Y., Wang, J., Yang, K., Bugno, J., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.04.019 · Cited by 251 · see citing works

Radiation-induced tumor immune microenvironments and potential targets for combination therapy

Guo, S., Yao, Y., Tang, Y., Xin, Z., Wu, D., Ni, C., Huang, J., Wei, Q., & Zhang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01462-z · Cited by 252 · see citing works

Curcumin as an anti‐inflammatory agent: Implications to radiotherapy and chemotherapy

Farhood, B., Mortezaee, K., Goradel, N. H., Khanlarkhani, N., Salehi, E., Nashtaei, M. S., Najafi, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27442 · Cited by 248 · see citing works

The double edge sword of fibrosis in cancer

Chandler, C., Liu, T., Buckanovich, R. J., & Coffman, L. G. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.006 · Cited by 248 · see citing works

Radiation effects on antitumor immune responses: current perspectives and challenges

Walle, T., Monge, R. M., Cerwenka, A., Ajona, D., Melero, I., & Lecanda, F. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017742575 · Cited by 242 · see citing works

Radiotherapy and immune response: the systemic effects of a local treatment

Carvalho, H. D. A., & Villar, R. C. (2018) · Clinics · doi:10.6061/clinics/2018/e557s · Cited by 244 · see citing works

Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming

Rodriguez-Ruiz, M. E., Rodríguez, I., Garasa, S., Barbés, B., Solórzano, J. L., Perez‐Gracia, J. L., Labiano, S., Sanmamed, M. F., Azpilikueta, A., Bolaños, E., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0549 · Cited by 238 · see citing works

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

Zhang, P., Rashidi, A., Zhao, J., Silvers, C., Wang, H., Castro, B. A., Ellingwood, A., Han, Y., Lopez‐Rosas, A., Ζαννίκου, Μ., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37328-9 · Cited by 241 · see citing works

Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases

He, W., Kapate, N., Shields, C. W., & Mitragotri, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.001 · Cited by 237 · see citing works

Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes

Iñarrairaegui, M., Melero, I., & Sangro, B. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0289 · Cited by 235 · see citing works

In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy

Yang, W., Zhu, G., Wang, S., Yu, G., Yáng, Z., Lin, L., Zhou, Z., Liu, Y., Dai, Y., Zhang, F., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b08346 · Cited by 236 · see citing works

Intratumoral Delivery of Immunotherapy—Act Locally, Think Globally

Aznar, M. A., Tinari, N., Rullan, A., Sánchez-Paulete, A. R., Rodriguez-Ruiz, M. E., & Melero, I. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601145 · Cited by 226 · see citing works

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy

Yan, Y., Kumar, A. B., Finnes, H. D., Markovic, S. N., Park, S. S., Dronca, R. S., & Dong, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01739 · Cited by 227 · see citing works

Harnessing the immune system in glioblastoma

Brown, N. F., Carter, T. J., Ottaviani, D., & Mulholland, P. J. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0258-8 · Cited by 221 · see citing works

Targeting Tumor Microenvironment and Metabolism to Overcome Radiation Resistance

Sharma, A., & Pruschy, M. N. (2018) · Progress in tumor research · doi:10.1159/000486986 · Cited by 2 · see citing works

The tumor microenvironment as a key regulator of radiotherapy response

Ma, X., & Zhang, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1776636 · Cited by 1 · see citing works

Radiation-induced tumor immune microenvironments and potential targets for combination therapy

Guo, S., Yao, Y., Tang, Y., Xin, Z., Wu, D., Ni, C., Huang, J., Wei, Q., & Zhang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01462-z · Cited by 252 · see citing works

Targeting Tumor Physical Microenvironment for Improved Radiotherapy

Wang, J., Han, Y., Li, Y., Zhang, F., Cai, M., Zhang, X., Chen, J., Ji, C., Ma, J., & Xu, F. (2022) · Small Methods · doi:10.1002/smtd.202200570 · Cited by 36 · see citing works

Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives

Byrne, N. M., Tambe, P., & Coulter, J. A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11010053 · Cited by 21 · see citing works